The following mAbs were added to 100 μL of whole blood: anti-CD45 (catalog 652803), anti-CD3 (catalog 663490), anti-CD4 (catalog 560345), anti-CD8 (catalog 335822), anti-CD28 (catalog 662797), anti–HLA-DR (catalog 652809), anti-CD45RA (catalog 662840), anti-CD45RO (catalog 663530), anti-CD25 (catalog 662525), anti-CD127 (catalog 560822), anti–PD-1 (catalog 557860), and anti–Tim-3 (catalog 565558) (all from BD Biosciences). Different T cell subsets were defined as following: costimulatory molecule (CD28+CD4+ or CD28+CD8+ T cells), activated T cells (HLA-DR+CD4+ or HLA-DR+CD8+ T cells), naive/memory CD4+ T cells (CD45RA+/CD45RO+ CD4+ T cells), Tregs (CD25hiCD127loCD4+ T cells), and natural Tregs (CD45RA+ Tregs). PD-1 and Tim-3 were also used as activation markers of T cells. Gating strategies of T cell subsets are shown in Supplemental Figure 1, A, B, and F.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.